NCT01327963View on ClinicalTrials.gov

Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study

NATerminatedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Gastroesophageal Reflux Disease (GERD)
Interventions
DEVICE

Transoral Incisionless Fundoplication

Transoral incisionless esophago-gastric fundoplication performed using the EsophyX (brand name) system with SerosaFuse (brand name) fasteners (EndoGastric Solutions, Inc., Redmond, Washington, USA) and following the standardized Transoral Incisionless Fundoplication 2.0 technique iteration (TIF2.0) protocol.

Trial Locations (2)

34471

Munroe Regional Medical Center, Ocala

42078

Livingston Hospital and Healthcare Services, Inc. CAH, Salem

Sponsors
All Listed Sponsors
lead

EndoGastric Solutions

INDUSTRY

NCT01327963 - Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study | Biotech Hunter | Biotech Hunter